3:19pm ET
Health and Healthcare
Why AbbVie Should Be Worth 25% More
Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.
Companies
/Healthcare
Abbvie Inc
$258.15
▼ $4.75 (−1.81%) today
Markets closed · 2:29am ET
ABBV Coverage
Page 38
8:21am ET
Health and Healthcare
Short Sellers Run For Cover From Major Pharma
ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials.…
9:10am ET
Health and Healthcare
Are AbbVie Earnings Enough?
AbbVie reported better-than-expected second-quarter financial results Friday before the markets opened.
Chris Lange 1:25pm ET
Health and Healthcare
What to Expect From AbbVie Earnings
Abbvie is scheduled to report its second-quarter financial results before the markets open Friday.
Chris Lange 9:35am ET
Health and Healthcare
Top Health Care Earnings for the Week Ahead
Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been on a roll for the past 12 months.
10:20am ET
Health and Healthcare
3 Top Big Pharmaceutical Stocks With Upcoming Catalysts
A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for investors now.
8:05am ET
Health and Healthcare
Short Sellers Run for Cover in Big Pharma
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
8:55am ET
Health and Healthcare
3 UBS Must-Own Large-Cap Pharmaceutical Stocks
A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay a solid dividend and have a good potential for growth, they all…
11:35am ET
Health and Healthcare
Is Big Pharma Advertising Getting Out of Control?
How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?
8:10am ET
Health and Healthcare
Short Sellers Become More Focused on Big Pharma
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
9:15am ET
Investing
Jefferies Franchise Stock Picks Crush S&P 500: 4 to Buy Now
We screened the Jefferies Franchise Pick List for top stocks rated Buy with the highest upside to the Jefferies price targets.
8:30am ET
Health and Healthcare
Short Sellers Back Off Big Pharma
The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest is down.
6:49am ET
Investing
The 6 Most Shorted NYSE Stocks in May
AT&T continued to reign as the most shorted stock trading on the New York Stock Exchange between the May 15 and May 29 settlement dates.
1:00pm ET
Health and Healthcare
Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
10:30am ET
Health and Healthcare
How Halozyme Will Continue to Grow With Its New Deal
Halozyme Therapeutics has announced a global collaboration and license agreement with AbbVie.